Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Spruce Biosciences, Inc. - Common Stock (NQ:SPRB)

130.40 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 486,882
Open 130.40
Bid (Size) 183.71 (1)
Ask (Size) 188.00 (10)
Prev. Close 130.40
Today's Range 130.40 - 130.40
52wk Range 7.260 - 3,420.00
Shares Outstanding 40,710,692
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Spruce Biosciences Stock Nearly Doubles Premarket: 'Pharma Bro' Martin Shkreli Sees 280% Upside
Via Stocktwits

Performance

YTD
-94.5%
-94.5%
1 Month
+1230.6%
+1230.6%
3 Month
+1230.6%
+1230.6%
6 Month
-91.5%
-91.5%
1 Year
-94.9%
-94.9%

More News

Read More
Spruce Biosciences (SPRB) Stock Jumps 30% After Hours Following Red Hot Rally On Monday: Here's Why
Via Benzinga
Why Spruce Biosciences Just Skyrocketed More Than 1,600%
Via Investor's Business Daily
Spruce Biosciences Stock More Than Quadruples After Breakthrough Therapy Designation To Therapy For Rare And Fatal Genetic Disease
Via Stocktwits
Nasdaq Jumps Over 150 Points; Skye Bioscience Shares Plunge
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Spruce Biosciences Stock Is Soaring Today: Here's Why
Via Benzinga
US Stocks Mixed; Dow Falls 100 Points
Via Benzinga
Topics Stocks
Wondering what's happening in today's pre-market session?
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB)
From Spruce Biosciences, Inc.
Via Business Wire
These stocks that are showing activity before the opening bell on Friday.
Via Chartmill
Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Spruce Biosciences Resumes Trading on the Nasdaq Capital Market
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences Announces Integrated Long-Term Clinical Data of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) Demonstrating Profound and Durable Efficacy and Safety in Patients with Sanfilippo Syndrome Type B (MPS IIIB)
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences Announces Reverse Stock Split
From Spruce Biosciences, Inc.
Via Business Wire
HMNC Brain Health and Spruce Biosciences Announce First Patient Dosed in Phase 2 TAMARIND Trial For Major Depressive Disorder
From HMNC Holding GmbH
Via GlobeNewswire
Spruce Biosciences Announces Conditional Nasdaq Approval to Resume Trading on the Nasdaq Capital Market
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Updates
From Spruce Biosciences, Inc.
Via Business Wire
Top movers analysis one hour before the close of the markets on 2025-04-28: top gainers and losers in today's session.
Via Chartmill
These stocks are moving in today's session
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga

Frequently Asked Questions

Is Spruce Biosciences, Inc. - Common Stock publicly traded?
Yes, Spruce Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Spruce Biosciences, Inc. - Common Stock trade on?
Spruce Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Spruce Biosciences, Inc. - Common Stock?
The ticker symbol for Spruce Biosciences, Inc. - Common Stock is SPRB on the Nasdaq Stock Market
What is the current price of Spruce Biosciences, Inc. - Common Stock?
The current price of Spruce Biosciences, Inc. - Common Stock is 130.40
When was Spruce Biosciences, Inc. - Common Stock last traded?
The last trade of Spruce Biosciences, Inc. - Common Stock was at 10/06/25 04:00 PM ET
What is the market capitalization of Spruce Biosciences, Inc. - Common Stock?
The market capitalization of Spruce Biosciences, Inc. - Common Stock is 5.31B
How many shares of Spruce Biosciences, Inc. - Common Stock are outstanding?
Spruce Biosciences, Inc. - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.